Study shows Smith and Nephew's REGENETEN(TM) Bioinductive Implant sets new standard of recovery for partial-thickness rotator cuff tears

LONDON, July 21, 2021 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (LSE:SN,NYSE:SNN), the global medical technology business, today announces study results showing patients treated with just its REGENETEN Bioinductive Implant for partial-th... Devices, Orthopaedic Smith & Nephew, REGENETEN Bioinductive Implant, rotator cuff tear
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news